Immunome issues 4,425,487 shares to Bristol-Myers Squibb in unregistered sale

Bitget2026/10/05 12:34

Immunome issued 4,425,487 common shares to Bristol-Myers Squibb in an unregistered sale tied to a license amendment. Consideration included USD 20 million cash; amendment eliminated all milestone, royalty, or other payment obligations to BMS. Company committed to file a resale registration statement for the shares by Nov. 16, 2026. Shares issued under Securities Act Section 4(a)(2) private placement exemption. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-413217), on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Viral Altcoin Defies Market Slumber With 53% Surge, BTC Calms at $83K: Weekend Watch

Cryptopotato•2026/10/11 10:21

Global Bank Stocks Sink as Bond Losses Top $326 Billion: Is Another SVB Coming?

BeInCrypto•2026/10/11 10:06

Exclusive Report - Sources Say INWIT Investors Are Raising Funds for a Possible Privatization Deal

路透社•2026/10/11 08:51

About 700,000 BTC have flowed out of exchanges in the past year.

AiCoin•2026/10/11 07:37